NCT04679623View on ClinicalTrials.gov

Study of Midazolam in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

September 17, 2021

Study Completion Date

September 17, 2021

Conditions
Status Epilepticus
Interventions
COMBINATION_PRODUCT

Midazolam

Midazolam Injection, 10mg

DRUG

Seizalam

Seizalam, 10 mg

Trial Locations (1)

27612

Wake Research, Raleigh

All Listed Sponsors
collaborator

Alachua Government Services, Inc.

INDUSTRY

collaborator

Joint Project Management Office for Chemical, Biological, Radiological, and Nuclear Medical

UNKNOWN

lead

Rafa Laboratories

INDUSTRY